Company / Revenue per Share
BioNexus Gene Lab Corp Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$4.13
FY2025
5-year range
$0.06 / $4.13
FY2021-FY2025
Trend
+667.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +668% YoY in FY2025, a notable deviation from the 6-year average annual change of +1329%.
Based on SEC 10-K filings.
4.13 in FY2025 with a 5-year CAGR of +106.2%.
Improved from $0.67 to $4.13 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +301.5%
- 5-Year CAGR
- +106.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 667.7% year-over-year.
- Lowest revenue per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.13 | +667.7% |
| FY2024 | $0.54 | -20.2% |
| FY2023 | $0.67 | +957.4% |
| FY2022 | $0.06 | -18.2% |
| FY2021 | $0.08 | -29.6% |
| FY2020 | $0.11 | +6417.6% |
| FY2019 | $0.00 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026